Faruqi & Faruqi, LLP Announces Shareholder Investigation Related To The Acquisition Of Bucyrus International Inc. - BUCY

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Bucyrus International Inc. (“Bucyrus” or the “Company”) (NASDAQ: BUCY) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Caterpillar Inc. (NYSE: CAT). The proposed transaction offers Bucyrus shareholders to only receive $92 per share in cash. According to Yahoo! Finance, at least one financial analyst values Bucyrus’ common stock at $95 per share. The transaction is valued at $7.6 billion and is expected to close in mid-2011.

Request more information now by clicking here: www.faruqilaw.com/BUCY

Whether the Bucyrus’s Board of Directors breached their fiduciary duties to Bucyrus’ stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Bucyrus’ shares and by how much this proposed transaction undervalues the Company to the detriment of Bucyrus shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Bucyrus and wish to obtain additional information, please visit us at www.faruqilaw.com/BUCY or contact Juan E. Monteverde, Esq. either via e-mail at [e-mail] or by telephone at [phone] or [phone].

Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

1 2 Next › Last »